Noa Biran, MD, talks about her thoughts on the promising combination of carfilzomib and daratumumab in revlimid-refractory multiple myeloma patients at the 2018 Annual Meeting.
Combination carfilzomib & daratumumab in revlimid-refractory multiple myeloma
